Exact Mass: 374.0452
Exact Mass Matches: 374.0452
Found 197 metabolites which its exact mass value is equals to given mass value 374.0452,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isodiospyrin
Isodiospyrin is a member of biphenyls. Isodiospyrin is a natural product found in Diospyros morrisiana, Diospyros verrucosa, and other organisms with data available. Isodiospyrin, a natural dimeric naphthoquinone, is a human DNA topoisomerase I (Topoisomerase) inhibitor. Isodiospyrin can prevent both DNA relaxation and kinase activities of human topoisomerase I. Isodiospyrin shows anticancer, antibacterial and antifungal activities[1][2][3]. Isodiospyrin, a natural dimeric naphthoquinone, is a human DNA topoisomerase I (Topoisomerase) inhibitor. Isodiospyrin can prevent both DNA relaxation and kinase activities of human topoisomerase I. Isodiospyrin shows anticancer, antibacterial and antifungal activities[1][2][3].
Chlorophacinone
D006401 - Hematologic Agents > D000925 - Anticoagulants D010575 - Pesticides > D012378 - Rodenticides D009676 - Noxae > D009153 - Mutagens D016573 - Agrochemicals
Neodiospyrin
Neodiospyrin is found in fruits. Neodiospyrin is isolated from roots of Diospyros kaki (Japanese persimmon
6-Hydroxymethyletoricoxib
6-Hydroxymethyletoricoxib is only found in individuals that have used or taken Etoricoxib. 6-Hydroxymethyletoricoxib is a metabolite of Etoricoxib. 6-hydroxymethyletoricoxib belongs to the family of Bipyridines. These are organic compounds containing two pyridine rings linked to each other.
N-Desmethylzopiclone
N-Desmethylzopiclone is a metabolite of Eszopiclone. Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic which is slightly effective for insomnia. Eszopiclone is the active dextrorotatory stereoisomer of zopiclone, and belongs to the class of drugs known as cyclopyrrolones. (Wikipedia)
Etoricoxib 1'-N'-oxide
Etoricoxib 1-N-oxide is a metabolite of etoricoxib. Etoricoxib (brand name NUSHIN MASCOT HEALTH SERIES Arcoxia worldwide; also Algix and Tauxib in Italy, Nucoxia in India) is a COX-2 selective inhibitor (approx. 106.0 times more selective for COX-2 inhibition over COX-1) from Merck & Co. Currently it is approved in more than 70 countries worldwide but not in the US, where the Food and Drug Administration (FDA) requires additional safety and efficacy data for etoricoxib before it will issue approval. (Wikipedia)
Ethyl gallate 3-glucuronide
Ethyl gallate 3-glucuronide belongs to the class of organic compounds known as hydrolyzable tannins. These are tannins with a structure characterized by either (1) galloyl units (in some cases, shikimic acid units) that are linked to diverse polyol carbohydrate-, catechin-, or triterpenoid units, or (2) at least two galloyl units C-C coupled to each other and without a glycosidically linked catechin unit. Ethyl gallate 3-glucuronide is an extremely weak basic (essentially neutral) compound (based on its pKa).
Ethyl gallate 4-glucuronide
Ethyl gallate 4-glucuronide belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans and flavonoids. Ethyl gallate 4-glucuronide is an extremely weak basic (essentially neutral) compound (based on its pKa).
Syringic acid glucuronide
(4-Methoxyphenyl)-morpholin-4-yl-morpholin-4-ylsulfanyl-sulfidophosphanium
Iguratimod
C308 - Immunotherapeutic Agent
(6'-Hydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate
Valeant
Sodium calcium edetate
Preservative and sequestrant in foods. Ethylenediaminetetraacetic acid, widely abbreviated as EDTA, is a polyamino carboxylic acid and a colourless, water-soluble solid. Its conjugate base is named ethylenediaminetetraacetate. It is widely used to dissolve limescale. Its usefulness arises because of its role as a hexadentate (six-toothed") ligand and chelating agent Preservative and sequestrant in foods
[2,2-Binaphthalene]-1,1,4,4-tetrone, 5,5-dihydroxy-7,7-dimethyl-
5,8-Dihydroxy-7,6-dimethyl-2,2-binaphthalene-1,1,4,4-tetraone
Paeciloquinone D
bromhexine
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 1173
Neodiospyrin
(5E,11E,15E,19E)-20-bromoeicosa-5,11,15,19-tetraen-9,17-diynoic acid|(all-E)-form-20-Bromo-5, 11, 15, 19-eicosatetraene-9, 17-diynoic aicd
1-(2,5-Dihydroxy-4-bromophenyl)-3,7-dihydroxy-3,7-dimethyl-1-octanone
Diospyrin, 1.1.4.4-Tetraoxo-7.7-dimethyl-5.5-dihydroxy-1.1.4.4-tetrahydro-binaphthyl-(2.6 oder 3.6)|Euclein
4,4-Dihydroxy-7,7-dimethyl-2,2-binaphthalene-5,5,8,8-tetraone
1-Hydroxy-2,3,7,8-tetramethoxy-chromeno[5,4,3-cde]chromen-5,10-dion|1-hydroxy-2,3,7,8-tetramethoxy-chromeno[5,4,3-cde]chromene-5,10-dione|3,3,4,4-tetra-O-methylflavellagic acid
impatienol
A hydroxy-1,4-naphthoquinone that is ethane in which one of the carbons is substituted by two 3-hydroxy-1,4-naphthoquinon-2-yl groups.
3,4,5,6tetrahydroxy-2-(3,4,5-trihydroxyphenoxy)biphenyl
7-Hydroxy-2-phenoxy-3-(2-carboxybenzyl)chromone
CHLOROPHACINONE
D006401 - Hematologic Agents > D000925 - Anticoagulants D010575 - Pesticides > D012378 - Rodenticides D009676 - Noxae > D009153 - Mutagens D016573 - Agrochemicals
6-Hydroxymethyletoricoxib
4-amino-n-[2-[(2-sulfoxy)ethyl]-sulfonyl]ethyl benzamide,sodium
1,1,1,7,7,7-hexafluoro-2,6-bis(trifluoromethyl)hept-3-ene-2,6-diol
Bis(1-ethyl-3-methylcyclopentadienyl)zirconium dichloride
Bis(1-ethyl-2-methylcyclopentadienyl)zirconium dichloride
acetic acid,4-bromo-6-(2-phenyl-1H-pyrazol-3-ylidene)cyclohexa-2,4-dien-1-one
(1S,2S)-1,2-Bis(4-nitrophenyl)-1,2-ethanediamine dihydrochloride
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanamide monohydrochloride
3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-[[(methylsulfonyl)oxy]methyl]-2-oxazolidinone
(R)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate
Edetate calcium disodium
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D000074385 - Food Ingredients > D005503 - Food Additives D006401 - Hematologic Agents > D000925 - Anticoagulants
Magnesium Ascorbate
D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins
4-chloro-1-tosyl-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
2-[2-[(3-Aminobenzoyl)amino]ethylsulfonyl]ethyl hydrogen sulfate
2,2:5,2'-Terthiophene-5-boronic acid pinacol ester
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
ethyl 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptanoate
ethene,3,3,4,4,5,5,6,6,6-nonafluorohex-1-ene,1,1,2,2-tetrafluoroethene
(2S,TRANS)-4-NITROBENZYL 2-(HYDROXYMETHYL)-4-((METHYLSULFONYL)OXY)PYRROLIDINE-1-CARBOXYLATE
N-(benzo[d][1,3]dioxol-5-yl)-2-(thiophen-2-yl)quinoline-4-carboxamide
4-Methylumbelliferyla-L-idopyranosiduronicacidsodiumsalt
6,8-difluoro-4-methyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
(1R,2R)-1,2-BIS(4-NITROPHENYL)ETHANE-1,2-DIAMINE DIHYDROCHLORIDE
3-iodo-4-(4-propan-2-ylpiperazin-1-yl)benzoic acid
4-[(4-ethylpiperazin-1-yl)methyl]-3-iodobenzoic acid
methyl 3-iodo-4-[(3-methylpiperazin-1-yl)methyl]benzoate
N-(4-Chlorobenzyl)-N-Methylbenzene-1,4-Disulfonamide
Gavestinel
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D018377 - Neurotransmitter Agents > D018684 - Glycine Agents
3,,4-Dihydro-2-(3-methoxyphenyl)-2h-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide
(2s)-({(5z)-5-[(5-Ethyl-2-Furyl)methylene]-4-Oxo-4,5-Dihydro-1,3-Thiazol-2-Yl}amino)(4-Fluorophenyl)acetic Acid
N-[2-[[3-chloro-5-(triluoromethyl)pyridin-2-yl]methylsulanyl]ethyl]benzamide
[(2R,3S,4R,5S)-3,4-dihydroxy-5-(5-methoxy-6-methylbenzimidazol-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
2-[[(5E)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-1,3-thiazolidin-2-ylidene]amino]-2-(4-fluorophenyl)acetic acid
ethyl (2Z)-5-phenyl-2-(1,1,1-trifluoro-3-methoxy-3-oxopropan-2-ylidene)-1,3-oxathiole-4-carboxylate
4-Fluorobenzoic acid 4-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)thio]but-2-ynyl ester
N-[(5-bromo-8-hydroxy-7-quinolinyl)-(2-furanyl)methyl]propanamide
3-Tert-butyl-7-[[2-(4-methylphenyl)-2-oxoethyl]thio]-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one
3-(3-bromophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one
3-Hydroxy-2-[5-[4-(trifluoromethyl)phenyl]-2-furanyl]-1,2-dihydroquinazolin-4-one
2-(4-chlorophenyl)-N-[(Z)-pyrrol-2-ylidenemethyl]cinchoninohydrazide
1-butyl-3-thiophen-2-ylsulfonyl-2H-imidazo[4,5-b]quinoxaline
1-[[2-(1,3-Benzothiazol-2-ylthio)-1-oxoethyl]amino]-3-phenylthiourea
2-(4-Chlorophenyl)-6-(phenacylthio)-2,3-dihydrothiopyran-4-one
2-(8,9-Dimethyl-thieno[3,2-e][1,2,4]triazolo[4,3-c]pyrimidin-3-ylsulfanyl)-N-(5-methyl-isoxazol-3-yl)-acetamide
6-[(1H-benzimidazol-2-ylthio)methyl]-1-phenyl-2H-pyrazolo[3,4-d]pyrimidin-4-one
Methyl 3-[2-(2,6-dichlorophenyl)quinolin-6-yl]alaninate
1-S-[(1Z)-N-(sulfonatooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose
2-(7-hydroxy-4-oxo-3-phenoxy-4H-chromen-2-yl)benzoic acid
glucocochlearin(1-)
An alkylglucosinolate that is the conjugate base of glucocochlearin.
isobutylglucosinolate
An alkylglucosinolate that is the conjugate base of isobutylglucosinolic acid.
butylglucosinolate
An alkylglucosinolate that is the conjugate base of butylglucosinolic acid.
BMS-984923
BMS-984923, a potent mGluR5 silent allosteric modulator (SAM), with exquisite binding affinity (Ki = 0.6 nM), exhibits good oral bioavailability and BBB penetration. BMS-984923 potently inhibits the PrPC-mGluR5 interaction and prevents pathological Aβo signaling without affecting physiological glutamate signaling[1][2].
Fatostatin (hydrobromide)
Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice[1][2].
Gavestinel
Gavestinel (GV 150526) is a selective and potent the glycine site of the NMDA receptor antagonist. Gavestinel has neuroprotectant effects[1].
(3r)-1-(4-bromo-2,5-dihydroxyphenyl)-3,7-dihydroxy-3,7-dimethyloctan-1-one
6'-(2,4,6-trihydroxyphenoxy)-[1,1'-biphenyl]-2,2',4,4',6-pentol
4,13,17-trihydroxy-5-methoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
(2r,3s,6s)-2-bromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undec-8-en-3-yl acetate
5-[2-(3,5-dihydroxyphenoxy)-3,5-dihydroxyphenoxy]benzene-1,2,3-triol
(1r,2s,3s,4as,9ar,10s)-9a-chloro-1,2,3,4a,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,10-tetrahydroanthracen-9-one
4-hydroxy-2-(1,3,6,8-tetrahydroxy-9,10-dioxoanthracen-2-yl)butanoic acid
3,8'-biplumbagin
{"Ingredient_id": "HBIN007821","Ingredient_name": "3,8'-biplumbagin","Alias": "NA","Ingredient_formula": "C22H14O6","Ingredient_Smile": "CC1=CC(=O)C2=C(C=CC(=C2C1=O)C3=C(C(=O)C4=C(C3=O)C(=CC=C4)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2403","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
